Mendelspod Podcast – Details, episodes & analysis

Podcast details

Technical and general information from the podcast's RSS feed.

Mendelspod Podcast

Theral Timpson

News

Frequency: 1 episode/8d. Total Eps: 561

Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.

www.mendelspod.com

Read moreCollapse

Site

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Apple Podcasts

🇨🇦 Canada - naturalSciences
15/08/2026
#97
🇨🇦 Canada - naturalSciences
10/08/2026
#98
🇨🇦 Canada - naturalSciences
09/08/2026
#81
🇨🇦 Canada - naturalSciences
08/08/2026
#66
🇨🇦 Canada - naturalSciences
07/08/2026
#60
🇨🇦 Canada - naturalSciences
06/08/2026
#45
🇩🇪 Germany - naturalSciences
04/07/2026
#94
🇺🇸 USA - naturalSciences
25/06/2026
#95
🇺🇸 USA - naturalSciences
23/06/2026
#92
🇺🇸 USA - naturalSciences
22/06/2026
#71

Spotify

No recent rankings available

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://www.mendelspod.com/subscribe?utm_medium=podcast&#38
509 shares
https://www.mendelspod.com?utm_medium=podcast&#38
52 shares
http://ancestry.com
4 shares

https://nam10.safelinks.protection.outlook.com/?url=https%253A%252F%252Fwww.nature.com%252Farticles%252Fs41586-023-06592-6&#38
2 shares
https://www.nature.com/articles/d41586-021-02483-w
1 share
https://www.nature.com/articles/s41592-020-01042-x
1 share

https://www.amazon.com/Determined-Science-Life-without-Free/dp/0525560971
1 share
https://www.amazon.com/Moving-Mountains-Socratic-Challenge-Population/dp/1634320301
1 share
https://www.amazon.com/Editing-Mankind-Humanity-CRISPR-Gene/dp/164313308X
1 share

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

RSS feed quality

To improve

Score global : 38%

Publication history

Monthly episode publishing history over the past years.

Year

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

What’s Next for Large-Scale Proteomics? With Chris Whelan, Janssen

Thursday, September 19, 2024 • Duration 22:33

Genetic studies of human populations have become a major tool for drug development. In the last few years, these studies have moved toward comprehensive proteomics profiling as well. In late 2023, a paper was published in Nature by the Pharma Proteomics Project, which characterized the plasma proteomic profiles of 54,219 UK Biobank participants. This was a precompetitive biopharmaceutical consortium that sought to provide a mapping of 2,923 proteins that identified 14,287 primary genetic associations, of which 81 percent were previously undescribed.

Chris Whelan was the lead author of this project paper, and he joins the show to discuss what’s next for these kinds of studies and their results. Whelan is a director of neuroscience on the data science and digital health team at Janssen Research & Development. He’s also chair and co-founder of the Pharma Proteomics Project.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Read moreCollapse

Will this At-Home Blood Collection Device Transform Medicine? Ben Casavant, Tasso

Tuesday, September 17, 2024 • Duration 05:17

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com

A new blood collection device offered by startup company Tasso is a blood lancet that collects whole liquid blood samples. Its ease of use for at-home collection could dramatically improve patient testing compliance and impact the scale of clinical trials.Ben Casavant is the co-founder and CEO of Tasso. He joins us to discuss the possibilities for at-home testing. Ben and the company have raised over $100 million dollars.

Read moreCollapse

Diagnostic Trends in 2024 with Mara Aspinall, Illumina Ventures

Thursday, June 27, 2024 • Duration 07:30

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com

One might think the pandemic would have been good for diagnostic companies. So why the financial hangover?Mara Aspinall has 30 years of leadership in genomics and the diagnostics industry. This has led her to her current role as a new partner at Illumina Ventures, a venture fund independent from Illumina that is focused on funding diagnostics and tools companies.Mara publishes the fantastic newsletter Sensitive and Specific and also a yearly report on industry trends, which is the topic of our show today. We discuss valuations, new regulations, and the latest science. Mara co-founded the Biomedical Diagnostics master’s degree program at Arizona State University, the only program dedicated exclusively to diagnostics, genetics, and genomics. How is the program faring, and how are we doing as a nation in educating the next generation on a revolution in diagnostic testing?

Read moreCollapse

Going High Resolution with 10X Genomics: Michael Schnall-Levin

Thursday, January 27, 2022 • Duration 37:33

Working at the Broad Institute early in his career, Michael Schnall Levin was discovering he was a biologist at heart. He’d begun his studies in physics then done his PhD in mathematics. But he'd wanted “to do math that had an application in the real world.” It was at the Broad that Michael came in contact with the new tools that were revolutionizing biology.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Read moreCollapse

George Church and Ben Lamm on the Launch of Colossal Biosciences

Thursday, January 20, 2022 • Duration 41:08

According to scientists, 30,000 species per year are going extinct. That’s 6 an hour, 150 per day. Up to one half of all species could be extinct by 2050.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Read moreCollapse

We Might Be the Comeback Kids of the Universe: Chris Mason on His Plan for the Next 500 Years

Tuesday, December 21, 2021 • Duration 47:10

Chris Mason is back on the program for our end-of-year special. He’s Professor of Genomics, Physiology, and Biophysics at Weill Cornell School of Medicine and the author of such an outstanding book that we had to have him on the program a second time this year.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Read moreCollapse

Invitae and PacBio CEOs Share Details of Clinical Sequencing Partnership

Tuesday, December 7, 2021 • Duration 52:34

In a joint interview, Sean George, CEO of diagnostics firm, Invitae, and Christian Henry, CEO of sequencing tools company, Pacific Biosciences, say that “it was clear in the first five minutes of a phone call that they shared a vision for doing something big together.”

What comes through the interview is that this partnership is built on a big vision: speeding up the adoption of whole genome sequencing into clinical medicine as the preferred method for genetic testing.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Read moreCollapse

Building on the Knowledge Base of Developer Community, LuminexPLORE Lab Offers Custom Insights: Jackie Surls, Director

Tuesday, November 30, 2021 • Duration 23:28

There are some technologies that become so ubiquitous in biomedical research that their name turns synonymous with their use. This has been the case for the Luminex xMAP platform and multiple biomarker analysis. The product has been applied in just about every area of life sciences including infectious disease, STD, organ transplant rejection, vaccine development, cancer research, immunodeficiency, animal testing, agriculture, and others. (xMAP is a research use only product and not for use in diagnostic procedures.)

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Read moreCollapse

DNA Script Takes DNA Synthesis Back to the Bench with Enzymatic Tech: Thomas Ybert, CEO

Wednesday, November 17, 2021 • Duration 28:31

DNA is a multibillion-dollar industry in 2021 and satisfies many life science applications, including drugs, reagents, siRNA, PCR, diagnostics, synthetic biology, and many others. Enzymatic DNA synthesis, or EDS, is a new approach to manufacturing DNA that is much more efficient and user-friendly and could disrupt the current market.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Read moreCollapse

Tumor Evolution in Context with Christina Curtis

Thursday, November 11, 2021 • Duration 29:28

If one was going to be a cancer researcher, surely one would want to be Christina Curtis. She’s an associate professor of oncology and genetics at Stanford, and she studies tumor evolution. She’s the Darwin of cancer research.

Because scientists can’t see human tumors evolve in real life, in Christina's lab she creates what she calls "virtual tumors that recapitulate the size and spatial properties of an actual tumor. And evaluating patient data,” she says, "we have found that metastatic seeding could happen very early. That these tumors were born to be bad.”

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

Read moreCollapse

Mendelspod Podcast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

Mendelspod Podcast – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Spotify

Shared links between episodes and podcasts

Other99+

Nature12

Amazon6

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Other99+

Nature12

Amazon6

Apple Podcasts

Spotify